About Neutron Therapeutics

Neutron Therapeutics is a medical equipment company founded in November 2015. We are working to bring Boron Neutron Capture Therapy (BNCT) out of the realm of medical research and transform it into a widely available first-line cancer therapy.

We see BNCT as an enabling tool for oncologists in the near future. To make this vision a reality, we will commercialize a revolutionary BNCT technology. At the same time, we will conduct the necessary clinical studies to make BNCT available to more of the patients who could benefit from this exciting technique.

Neutron Therapeutics is a global company with offices in Danvers, Massachusetts and Helsinki, Finland.

Our Board of Directors

Bill Buckley, Chairman

Ted Smick,
Chief Technology Officer

Alain Harrus, PhD, Director

Our Management Team

Noah Smick, PhD,
President & Chief Operating Officer

Ted Smick,
Chief Technology Officer

Matthew Copeland,
Chief Financial Officer

Paul Eide,
Vice President of Equipment Engineering

Hanna Koivunoro, PhD,
Chief Medical Physicist

Angel Estrada, Ph.D.,
Senior Vice President of Regulatory & Quality


Heikki Joensuu, MD, PhD,
Chairman of the Scientific Advisory Board

Tetsuya Yamamoto MD, PhD,
Medical Advisor

Feroz Agad,

Geoffrey Ryding, PhD,
Technical Advisor